135 related articles for article (PubMed ID: 23949270)
1. An under-recognized cause of polyarthritis: leprosy.
Ker KJ; Pan JY; Lui NL; Tey HL
Ann Acad Med Singap; 2013 Jul; 42(7):366-7. PubMed ID: 23949270
[No Abstract] [Full Text] [Related]
2. Painless Nodular Rash in a Young Man.
Bass M; Foster K; Studdiford J
Am Fam Physician; 2017 Aug; 96(3):189-190. PubMed ID: 28762689
[No Abstract] [Full Text] [Related]
3. Shiny red-brown papules in a 21-year-old man. Histoid leprosy.
Aranda J; Hoang MP; Cohen JB
Arch Dermatol; 2004 Jun; 140(6):751-6. PubMed ID: 15210473
[No Abstract] [Full Text] [Related]
4. Chemotherapy of leprosy; "bubble" or "calendar" packs for the administration of rifampin, dapsone, clofazimine, or prothionamide/ethionamide.
Winsley BE; McDougall AC; Brown KE
Int J Lepr Other Mycobact Dis; 1983 Dec; 51(4):592-4. PubMed ID: 6686974
[No Abstract] [Full Text] [Related]
5. New approaches to chemotherapy for leprosy.
Waters MF
Drugs; 1983 Dec; 26(6):465-7. PubMed ID: 6653446
[No Abstract] [Full Text] [Related]
6. [Polyarthritis and papular eruption revealing leprosy].
Meyer M; Ingen-Housz-Oro S; Ighilahriz O; Wendling J; Gaulier A; Levy-Weil F; Sigal-Grinberg M; Flageul B
Rev Med Interne; 2008 Mar; 29(3):242-5. PubMed ID: 17976874
[TBL] [Abstract][Full Text] [Related]
7. Lest we forget Hansen's disease (leprosy): an unusual presentation with an acute onset of inflammatory polyarthritis and the rheumatology experience.
Sheetal S; Arvind C
Int J Rheum Dis; 2009 Apr; 12(1):64-9. PubMed ID: 20374320
[TBL] [Abstract][Full Text] [Related]
8. Leprosy.
Indian J Med Sci; 1997 Dec; 51(12):482. PubMed ID: 9715550
[No Abstract] [Full Text] [Related]
9. [Field experiences with therapy protocols in leprosy].
Pattyn SR
Verh K Acad Geneeskd Belg; 1983; 45(3):303-14. PubMed ID: 6364614
[No Abstract] [Full Text] [Related]
10. [Combination chemotherapy in leprosy].
Leiker DL
Ned Tijdschr Geneeskd; 1986 Oct; 130(43):1926-9. PubMed ID: 3774040
[No Abstract] [Full Text] [Related]
11. Multidrug therapy regimen for leprosy.
Firooz A
J Am Acad Dermatol; 2006 Dec; 55(6):1115; author reply 1115. PubMed ID: 17110233
[No Abstract] [Full Text] [Related]
12. Treatment of leprosy.
Kar HK; Gupta R
Clin Dermatol; 2015; 33(1):55-65. PubMed ID: 25432811
[TBL] [Abstract][Full Text] [Related]
13. Combined chemotherapy of multibacillary leprosy of 6 months' duration.
Onsun N; Saylan T; Pattyn SR
Lepr Rev; 1986; 57 Suppl 3():124-6. PubMed ID: 3573952
[No Abstract] [Full Text] [Related]
14. The future of leprosy in the Dominican Republic: experience with multidrug therapy.
Martinez Cruz D
Lepr Rev; 1986; 57 Suppl 3():127-33. PubMed ID: 3573953
[No Abstract] [Full Text] [Related]
15. [New WHO recommendations for the treatment of leprosy].
Acta Leprol; 1997; 10(4):189. PubMed ID: 9527754
[No Abstract] [Full Text] [Related]
16. Dapsone drug resistance in the MDT era.
Roche PW; Neupane KD; Failbus SS; Butlin CR
Int J Lepr Other Mycobact Dis; 2000 Sep; 68(3):323-5. PubMed ID: 11221097
[No Abstract] [Full Text] [Related]
17. Hemolytic anemia in patients receiving daily dapsone for the treatment of leprosy.
Deps P; Guerra P; Nasser S; Simon M
Lepr Rev; 2012 Sep; 83(3):305-7. PubMed ID: 23356031
[TBL] [Abstract][Full Text] [Related]
18. Multidrug therapy (MDT) and leprosy control.
Noordeen SK
Indian J Lepr; 1990; 62(4):448-58. PubMed ID: 2086680
[No Abstract] [Full Text] [Related]
19. Why multidrug therapy for multibacillary leprosy can be shortened to 12 months.
Ji B
Lepr Rev; 1998 Jun; 69(2):106-9. PubMed ID: 9715593
[No Abstract] [Full Text] [Related]
20. Developing new MDT regimens for MB patients; time to test ROM 12 month regimens globally.
Lockwood DN; Cunha Mda G
Lepr Rev; 2012 Sep; 83(3):241-4. PubMed ID: 23356024
[No Abstract] [Full Text] [Related]
[Next] [New Search]